Inge Vereycken

Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development

H. V. van Vlijmen, A. Bender, G. V. van Westen, 2011, PloS one.

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

K. Hertogs, Peggy Geluykens, Inge Vereycken, 2008, Journal of Virology.

A homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion.

Inge Vereycken, Emmanuel Gustin, M. Van Loock, 2013, Methods in molecular biology.

Biochemical screening assays to identify HIV-1 integrase inhibitors.

Inge Vereycken, R. Clayton, M. Van Loock, 2013, Methods in molecular biology.

A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion

K. Hertogs, Inge Vereycken, Emmanuel Gustin, 2007, Journal of biomolecular screening.